Clinical Trial Update: MK0767 and Metformin Combination Study (0767-028) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating MK0767 in combination with metformin for diabetes mellitus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• MK0767
• metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED